Organisation paid for research Program year 2025 Source: CMS Open Payments

L-Marc Research Center

Neither a doctor nor a teaching hospital

Research payments

$1,195,518

943 payments

Through program year 2025, L-Marc Research Center is reported as receiving $1,195,518 in research payments, across 943 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $66,670 162
2024 Research $150,212 6
2023 Research $20,421 4
2022 Research $11,190 6
2021 Research $22,413 143
2020 Research $197,445 183
2019 Research $727,167 439

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novo Nordisk AS $755,851 582 payments
  2. Akcea Therapeutics, Inc. $151,637 37 payments
  3. Amgen Inc. $112,780 3 payments
  4. Ionis Pharmaceuticals, Inc. $55,505 17 payments
  5. Boehringer Ingelheim International GmbH $38,429 145 payments
  6. Boehringer Ingelheim France S.A.S. $21,261 142 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $16,361 9 payments
  8. Merck Sharp & Dohme Corporation $16,318 1 payment
  9. Amarin Pharma Inc. $16,186 1 payment
  10. Biohaven Pharmaceutical Holding Company Ltd. $11,190 6 payments
Studies the money was for Research payments · program years 2019–2025
  1. Nn9536-4373 $252,477 46 payments
  2. Nn9536-4376 $116,730 33 payments
  3. P4 Uncontrolled Gout FORWARD II $111,842 1 payment
  4. Isis 678354-Cs2 $102,782 29 payments
  5. Nn9536-4374 $98,127 36 payments
  6. Ex9924-4473 $94,436 158 payments
  7. Ex9536-4388 $83,648 119 payments
  8. Nn9535-4352 $49,702 90 payments
  9. A Randomized, Double-blind, Placebo-Controlled, Dose-Ranging Phase 2 Study of ISIS 678354 Administered Subcutaneously to Patients With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) or at a High Risk for CVD $48,856 8 payments
  10. Nn9535-4506 $32,646 91 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record